NEW YORK (360Dx) – Ambry Genetics, a Konica Minolta company, said this week that it is collaborating with the National Institutes of Health-funded Undiagnosed Diseases Network to "facilitate transition" of patients with negative or uncertain test results to the UDN in hopes of providing them with answers.